This article explains, in educational terms, coronary guidewire — how the technology works and where it fits. Coronary artery disease develops when atherosclerotic plaque accumulates within the arteries that supply the heart muscle, gradually narrowing the lumen and limiting blood flow. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Coronary Artery Disease and Percutaneous Coronary Intervention
During PCI a lesion is usually crossed with a guidewire, prepared with a balloon, and in most cases scaffolded with a stent that holds the vessel open. Contemporary practice relies heavily on drug-eluting stents, which release an antiproliferative agent to limit the tissue overgrowth that can cause restenosis. When a narrowing becomes flow-limiting, patients may experience angina on exertion, and an abrupt plaque rupture with thrombosis can precipitate a myocardial infarction.
Coronary and CTO Guidewires
The guidewire is the rail on which balloons and stents are advanced, and different tip loads and coatings suit workhorse versus chronic total occlusion (CTO) work. Workhorse wires prioritize trackability and support, while dedicated CTO wires are designed to penetrate and cross resistant occlusions. INVAMED's Inwire PTCA Guidewire is offered for coronary wiring within the interventional line, alongside CTO and workhorse options. Wire selection is a hands-on decision made by the operator according to lesion morphology and crossing strategy.
Design and Technical Notes
INVAMED groups its coronary portfolio around the sequence of a PCI case, offering access, lesion preparation, drug delivery, scaffolding, and closure devices. Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes. All INVAMED coronary devices are intended for use by trained interventional cardiologists under fluoroscopic guidance and per the IFU.
Key Considerations
- Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes.
- Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy.
- Dual antiplatelet therapy duration is individualized to the clinical presentation and the patient's bleeding risk.
Frequently Asked Questions
What is the reported restenosis performance of the ATLAS DES?
INVAMED reports clinical data showing target lesion revascularization rates below 5% at 12 months; this reflects studied performance and is not an individual guarantee.
What is the INVAMED drug-eluting stent called?
INVAMED's drug-eluting coronary stent is the ATLAS Drug Eluting Coronary Stent System, built on a cobalt-chromium L605 platform with a sirolimus coating.
Does INVAMED make a drug-coated coronary balloon?
Yes. The Extender Drug Eluting PTCA Balloon Catheter carries a paclitaxel coating for local drug delivery, such as in-stent restenosis or small-vessel disease.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
Coronary artery disease develops when atherosclerotic plaque accumulates within the arteries that supply the heart muscle, gradually narrowing the lumen and limiting blood flow. INVAMED's Atlas line spans a cobalt-chromium drug-eluting version, a bare cobalt-chromium version described as offering high radial strength with minimal recoil, and a stainless-steel version. Wire selection is a hands-on decision made by the operator according to lesion morphology and crossing strategy. Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy. Because a drug-coated balloon leaves nothing behind, it is one option a clinician may weigh when a metallic implant is less desirable. According to INVAMED, clinical data for the ATLAS DES show target lesion revascularization rates below 5% at 12 months, a figure that reflects studied performance rather than an individual guarantee. Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery. All INVAMED coronary devices are intended for use by trained interventional cardiologists under fluoroscopic guidance and per the IFU.
Related on INVAMED
- Coronary Artery Disease & Cardiac Interventions — product category
- Cobalt-Chromium and Stainless-Steel Stent Options Explained — A Technical Guide
- Drug-eluting stent or Bare-metal stent? A Technical Comparison
- Choosing a Coronary Artery Disease & Cardiac Interventions Supplier: What Buyers Should Know
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.